Lloyds Banking Group PLC Delivers On Dividend Promise: Time To Buy?

Lloyds Banking Group PLC (LON:LLOY) delivered a pleasant surprise to investors this morning. Is it time to top up?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lloyds Banking Group (LSE: LLOY) rose by almost 10% to 68p when markets opened this morning, after the bank announced a 2015 dividend of 2.75p per share.

The bank surprised investors when it announced a special dividend of 0.5p per share, on top of the expected ordinary dividend of 2.25p. The 2.75p total payout gives a healthy 4% yield at current prices.

The bumper dividend payout was not the only good news in today’s final results.

Should you invest £1,000 in Lloyds Banking Group right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Lloyds Banking Group made the list?

See the 6 stocks

Lloyds said that underlying profit rose by 5% to £8.1bn and that the bank’s net interest margin, a key measure of profitability, rose from 2.4% to 2.63% in 2015. Underlying earnings per share were 8.5p, slightly ahead of forecasts of 8.27p.

In my view, today’s results confirmed Lloyds’ position as one of the most profitable and well-financed of all the big UK banks. Lloyds’ CET1 ratio of capital strength rose from 12.8% to 13% last year, while its underlying return on equity rose from 13.6% to 15%. These are very solid figures.

UK focus pays off

One reason for Lloyds’ strong performance is its simple UK-only banking model. The group doesn’t have an investment bank, nor does it operate overseas. This helps to keep costs down.

In 2015, Lloyds’ costs only accounted for 49.3% of the bank’s income. By contrast, Barclays reported a cost-to-income ratio of 65% for the first nine months of last year. It’s much harder to make a decent profit when your costs are so high.

Was there any bad news?

Lloyds said this morning that it would allocate a further £2.1bn to PPI claims. This takes the 2015 total to £4bn, and means the bank has now spent a total of £16bn on PPI compensation.

The bank believes that the proposed deadline for PPI compensation could cause a surge in claims, hence today’s increase. However, Lloyds believes the allocations made in 2015 will be enough to cover all remaining PPI claims.

This news overshadowed the much better news on bad debts. Lloyds said that bad debt charges fell by 48% to £568m last year, reflecting an improvement in loan quality.

What next for Lloyds?

Last year’s government share sales saw the taxpayer’s stake in the bank fall to 9%. Sales were suspended when the share price fell below the government’s break-even level of 73.6p. This left the market uncertain about whether the planned discounted offering for private investors is still likely to go ahead.

Shares in Lloyds have risen by 22% over the last two weeks, but will still need to rise by at least another 8% before the Treasury will give the green light for further sales.

Should you buy?

Personally, I wouldn’t wait to buy in the hope that the government’s promised discounted offering will go ahead. I don’t see the logic in waiting — not least because in the meantime, you may be missing out on dividend income and potential capital gains.

I’d argue that Lloyds is a solid buy on the back of today’s results. Although profits are expected to fall slightly in 2016, the shares trade on just nine times 2016 forecast profits and offer a forecast 2016 yield of 5.4%. Both figures seem attractive to me.

Should you invest £1,000 in Lloyds Banking Group right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Lloyds Banking Group made the list?

See the 6 stocks

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of Barclays. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Up 7.5% in a week! Is the GSK share price about to do an AstraZeneca?

Harvey Jones says the GSK share price has dramatically underperformed FTSE 100 rival AstraZeneca, which has had a stellar run.…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

The dividend yield on this FTSE 100 stock has jumped 50% in a year. Time to buy?

Jon Smith explains why the yield on a FTSE 100 share has risen sharply over the past year but details…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

AstraZeneca’s share price is down 20% from September, so is it time for me to buy?

AstraZeneca’s share price has fallen a long way this year, which could mean a bargain to be had, so I…

Read more »

Man smiling and working on laptop
Investing Articles

2 top gold ETFs to consider in May!

Buying a gold exchange traded fund this month is a great idea to consider as the precious metal targets new…

Read more »

Nottingham Giltbrook Exterior
Investing Articles

Could the Marks and Spencer cyberattack send its share price plummeting?

Marks and Spencer’s share price has already taken a hit as a result of the cyberattack on the company. Could…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

3 dirt cheap FTSE 250 shares for May

I think these FTSE 250 shares could be among the London stock market's best bargains to consider following recent turbulence.

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

£500 to invest in an ISA each month? Here’s how to target a potential £60k+ second income!

A regular monthly investment in a Stocks and Shares ISA could build a huge passive income in retirement. Let me…

Read more »

Departure & Arrival sign, representing selling and buying in a portfolio
Investing Articles

£10,000 invested in Jet2 shares 1 year ago is now worth…

Jet2 shares jumped on Tuesday 29 April after a positive trading report boosted investor sentiment. Dr James Fox explores his…

Read more »